Zenas BioPharma, Inc. Operating Lease Liability
Zenas BioPharma, Inc. (ZBIO) had Operating Lease Liability of $1.33 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-16
- 2025-12-31: Operating Lease, Liability $1.33M.
- 2025-09-30: Operating Lease, Liability $798.00K.
- 2025-06-30: Operating Lease, Liability $1.01M.
- 2025-03-31: Operating Lease, Liability $1.23M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $1.33M 10-K · filed 2026-03-16 |
| 2025-09-30 | $798.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.01M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.23M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.00M 10-K · filed 2026-03-16 |
| 2024-09-30 | $384.00M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $813.00K 10-K · filed 2025-03-11 |